T cell receptor binding transition states and recognition of peptide/MHC.

T cell receptor binding transition states and recognition of peptide/MHC. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

T cell receptor binding transition states and recognition of peptide/MHC. Abstract Text:

Rebecca L Davis-Harrison,Francis K Insaidoo,Brian M Baker,

T cell receptor recognition of peptide/MHC has been described as proceeding through a "two-step" process in which the TCR first contacts the MHC molecule prior to formation of the binding transition state using the germline-encoded CDR1 and CDR2 loops. The receptor then contacts the peptide using the hypervariable CDR3 loops as the transition state decays to the bound state. The model subdivides TCR binding into peptide-independent and peptide-dependent steps, demarcated at the binding transition state. Investigating the two-step model, here we show that two TCRs that recognize the same peptide/MHC bury very similar amounts of solvent-accessible surface area in their transition states. However, 1300-1500 A2 of surface area is buried in each, a significant amount suggestive of participation of peptide and associated CDR3 surface. Consistent with this interpretation, analysis of peptide and TCR variants indicates that stabilizing contacts to the peptide are formed within both transition states. These data are incompatible with the original two-step model, as are transition state models built using the principle of minimal frustration commonly employed in the investigation of protein folding and binding transition states. These findings will be useful in further explorations of the nature of TCR binding transition states, as well as ongoing efforts to understand the mechanisms by which T cell receptors recognize the composite peptide/MHC surface.

T cell receptor binding transition states and recognition of peptide/MHC. Publishing Authors By Initials

RL Davis-Harrison,FK Insaidoo,BM Baker,

For similar natural sciences: physics: thermodynamics research abstracts see: natural sciences: physics: thermodynamics research

PUBMED ID PMID:

MEDLINE DATE:

T cell receptor binding transition states and recognition of peptide/MHC. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Biochemistry

VOLUME: 46

Page Numbers: 1840-50

Journal Abbreviation: Biochemistry

ISSN: 0006-2960

DAY: 24

MONTH: 01

YEAR: 2007

T cell receptor binding transition states and recognition of peptide/MHC. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370623

T cell receptor binding transition states and recognition of peptide/MHC. Keywords Mesh Terms:

KEYWORDS: Thermodynamics

MESH TERMS: metabolism

Chemical & Substance for Abstract: T cell receptor binding transition states and recognition of peptide/MHC. Information

Substance Name: leucyl-leucyl-phenylalanyl-glycyl-tyrosy

Registry Number: 0

Grant and Affiliation Information for T cell receptor binding transition states and recognition of peptide/MHC.

AFFILIATION: Department of Chemistry and Biochemistry and Walther Cancer Research Center, 251 Nieuwland Science Hall, University of Notre Dame, Notre Dame, Indiana 46556, USA.

Country: United States

AGENCY: United States NIGMS

GRANT: GM067079

ACRONYM: GM

MEDLINETA: Biochemistry

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

T cell receptor binding transition states and recognition of peptide/MHC Related Publications

• A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma.
• A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay.
• AUTO3DEM--an automated and high throughput program for image reconstruction of icosahedral particles.
• Ab initio random model method facilitates 3D reconstruction of icosahedral particles.
• An accelerated state of myosin-based actin motility.
• Analyses of RAS Regulation of Eye Development in Drosophila melanogaster.
• Assessing tobacco dependence: a guide to measure evaluation and selection.
• Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care.
• Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells.
• Deubiquitinating activity of the SARS-CoV papain-like protease.
• Effect of opening midlevel neonatal intensive care units on the location of low birth weight births in California.
• Enhancement of natural and experimental respiratory mycoplasmosis in rats by hexamethylphosphoramide.
• Evaluation of public health response to hurricanes finds North Carolina better prepared for public health emergencies.
• HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.
• HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein.
• HPLC separation of different generations of poly(amidoamine) dendrimers modified with various terminal groups.
• Health literacy and health risk behaviors among older adults.
• Hyperoxic and hyperbaric-induced cardioprotection: role of nitric oxide synthase 3.
• Hypoxia-inducible factor 1 in lower limb ischemia.
• Inmate-made weapons in prison facilities: assessing the injury risk.
• Iopamidol-induced meningoencephalopathy in an HIV-seropositive patient.
• Modulation of the antioxidant defence as a factor in apoptosis.
• Ovarian response, ova recovery and fertility in merino ewes superovulated either during the luteal phase of their oestrous cycle or after intravaginal progestagen treatment.
• Phosphodiesterase-5 inhibitors and omental and placental small artery function in normal pregnancy and pre-eclampsia.
• Protein polymorphism and the rate of loss of duplicate gene expression.
• Resurfacing flaps in reconstructive rhinoplasty.
• Superovulation in the prepuberal calf.
• T cell receptor binding transition states and recognition of peptide/MHC.
• T cell receptor recognition via cooperative conformational plasticity.
• Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate ABT-751, ABT-751 glucuronide, and ABT-751 sulfate in human plasma for clinical pharmacology studies.